AKT1 and non-small cell lung carcinoma: In this study, we found that the phosphorylation levels of AKT and S6 were increased in PD-1high ILC2s, indicating that the PD-1 downstream signaling pathway could be activated in ILC2s obtained from NSCLC patients.